Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Operating Expenses (2016 - 2025)

Skinvisible's Operating Expenses history spans 16 years, with the latest figure at $111057.0 for Q3 2025.

  • For Q3 2025, Operating Expenses fell 14.55% year-over-year to $111057.0; the TTM value through Sep 2025 reached $600889.0, up 9.77%, while the annual FY2024 figure was $609589.0, 19.44% up from the prior year.
  • Operating Expenses for Q3 2025 was $111057.0 at Skinvisible, down from $141237.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $203743.0 in Q4 2024 and bottomed at $105315.0 in Q4 2021.
  • The 5-year median for Operating Expenses is $128184.0 (2024), against an average of $131688.2.
  • The largest annual shift saw Operating Expenses decreased 17.92% in 2021 before it surged 43.95% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $105315.0 in 2021, then increased by 16.52% to $122716.0 in 2022, then increased by 15.34% to $141538.0 in 2023, then soared by 43.95% to $203743.0 in 2024, then tumbled by 45.49% to $111057.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Operating Expenses are $111057.0 (Q3 2025), $141237.0 (Q2 2025), and $144852.0 (Q1 2025).